Bernstein upgrades J&J, says valuation is 'historically cheap'

Amid Johnson & Johnson's legal battles the worst case is already priced into the stock and it's now a buy, according to Bernstein.

More In Pro News and Analysis

CNBC ProHousing data and retail could be the next catalysts for the market in week ahead
CNBC ProConsider these lesser-known semiconductor names poised to benefit from the CHIPS Act going forward
CNBC ProThese are the best-performing S&P 500 stocks this week. Here's where analysts see them going